Survey of infection control policies for patients with cystic fibrosis in the United States

Am J Infect Control. 2008 Apr;36(3):220-2. doi: 10.1016/j.ajic.2007.05.009.


Written infection control policies used at cystic fibrosis (CF) care sites in the United States were compared with recently published guidelines. Most policies recommended contact precautions for hospitalized patients infected with Burkholderia cepacia complex (73%), multidrug-resistant organisms (63%), and methicillin-resistant Staphylococcus aureus (64%). Socializing among CF patients was discouraged in 80% of inpatient policies and 55% of outpatient policies. Although routine mask use by patients remains an unresolved issue, many policies advocated this practice. Future studies should address barriers to implementation of these evidence-based guidelines and continue to monitor implementation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Infections / prevention & control*
  • Bacterial Infections / transmission*
  • Cross Infection / prevention & control*
  • Cross Infection / transmission*
  • Cystic Fibrosis / complications*
  • Health Policy
  • Health Services Research
  • Humans
  • Infection Control / methods*
  • Organizational Policy
  • United States